Navigation Links
Stopping Prostate Cancer from Spreading

Prostate cancer is most likely to be deadly when tumor cells spread to the rest of the body. Now, researchers have identified a protein that may be able to predict a tumor’s growth pattern, and thus, save the lives of many patients.
Researchers from the University of Michigan Comprehensive Cancer Center are studying a protein called RKIP, which controls the ability of cancer cells to leave their original location and enter nearby blood vessels.// After entering the blood vessels, cells can easily spread to the rest of the body.Results of the study show RKIP plays a vital role in vascular invasion, the term for what happens before a tumor spreads.

Tumors that produce a normal amount of RKIP are unable to spread to the vascular system. Those that lack RKIP allow for metastasis to take place.

Researchers autopsied the bodies of prostate cancer patients within hours of their deaths. The RKIP protein was not detected in any of the 22 samples of tissue where cells had spread. RKIP was detected in 10 samples of non-cancerous tissue and in 12 samples of non-metastatic cancerous tissue.

Metastatic cancer cells that were given extra RKIP showed a nearly 50-percent decrease in their ability to spread. The ability to spread almost doubled in the non-metastatic cancer cells when RKIP production was stunted. Thus, a normal amount of RKIP can keep a tumor from spreading.

Researchers say their results are promising. "These findings bring home the point that if you can stop even one gene in the cascade, you can slow the process down.
'"/>




Page: 1

Related medicine news :

1. Stopping The Progression Of Parkinsons Disease
2. Stopping The Growth Of Viruses
3. Stopping The Growth Of Viruses
4. The Consequences Of Stopping Physical Activity
5. Study Finds Parkinson’s Cell Death Blocked by Stopping Inflammatory Facto
6. The Odds Of Stopping Smoking
7. Cancer Doctors Okays Controversial Prostate Therapy
8. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
9. New Prostate Cancer Vaccine Shows Promise
10. Hormone Therapy applicable for Prostate Cancer
11. Prostate cancer and Vitamins
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... April 24, 2017 , ... The world-class ... support to bring their novel lifesaving device for the everyday use of parents ... sensors, specially designed to read a child’s vital signs, and detect unusual symptoms ...
(Date:4/24/2017)... Ill., and Waycross, Ga. (PRWEB) , ... April ... ... market leader and trusted advisor within the telehealth industry, announces the company’s VideoMedicine ... U.S. board-certified primary care providers. Available 24 hours a day, Quick Care provides ...
(Date:4/24/2017)... ... April 24, 2017 , ... According ... overdose deaths now claim the lives of 62 Americans each day.(1) Yet since ... drug manufacturers, distributors, pharmacies and prescribers by more than half.(2) Novus Medical ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... recognize elevated anxiety levels in people with addiction who are served by MAP’s ... a biosensing wearable device that monitors heart and breath rates to identify anxiety ...
(Date:4/24/2017)... ... 2017 , ... Pitavastatin, a relatively new statin, has relevance ... to have significant interactions with antiretroviral therapy (ART). Among people living with ... inflammation in the bloodstream. , While lowering cholesterol and dampening inflammation are beneficial ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)...  IRIDEX Corporation (Nasdaq: IRIX ) today ... first quarter 2017 after the close of trading on ... host a corresponding conference call beginning at 2:30 p.m. ... in listening to the conference call may do so ... 326-3030 for international callers, using conference ID: 92158987.  A ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
Breaking Medicine Technology: